Neoplasms

All Conditions

Infections

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Symptoms and General Pathology

Mouth and Tooth Diseases

Digestive System Diseases

Ear, Nose, and Throat Diseases

Rare Diseases

Carcinoma

Uterine Cervical Neoplasms

Communicable Diseases

Vulvar Neoplasms

Papillomavirus Infections

Mouth Neoplasms

Anus Neoplasms

Oropharyngeal Neoplasms

Penile Neoplasms

Genital Neoplasms, Female

Urogenital Neoplasms

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Rectal Neoplasms

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Intestinal Diseases

Anus Diseases

Rectal Diseases

Vulvar Diseases

Head and Neck Neoplasms

Mouth Diseases

Stomatognathic Diseases

Pharyngeal Neoplasms

Otorhinolaryngologic Neoplasms

Pharyngeal Diseases

Otorhinolaryngologic Diseases

Genital Neoplasms, Male

Genital Diseases, Male

Penile Diseases

Male Urogenital Diseases

Penile Cancer

Oral Cancer

Anal Cancer

Vulvar Cancer

20 ml of blood sample will be made before the beginning of all treatment. This blood sample will be sent to the CERBA Laboratory for analysis.

In parallel, a standard anatomopathological and virological analysis will be carried out from a biopsy or from a tumor sample by the Tumor Biology Unit at Lorraine Institute of Oncology

The results of both analyzes will be compared blindly.

CaptHPV method

SASTRE-GARAU Xavier, MD

The current project is based on the assumption that a diagnosis of human papillomavirus associated Infiltrating Carcinomas can be made from a blood sample for patient with Cervical Cancer, Vulvar Cancer, Anal Cancer, Oropharynx Cancer, Oral Cavity Cancer or Penis Cancer at any stage of the disease and including surgical treatment for the small tumors.

CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas

Monocentric Study of Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas From a Biological Specimen.

The diagnostic value of the serum marker provided by the method CaptHPV will be assessed in sensitivity and specificity to results of histological and virological analyzes of a sample tumor.

Institut de Cancérologie de Lorraine

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas	NCT02981862	Cervical Cancer Vulvar Cancer Anal Cancer Oropharynx Canc... Oral Cavity Can... Penis Cancer	CaptHPV method	18 Years -	Institut de Cancérologie de Lorraine
CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas	NCT02981862	Cervical Cancer Vulvar Cancer Anal Cancer Oropharynx Canc... Oral Cavity Can... Penis Cancer	CaptHPV method	18 Years -	Institut de Cancérologie de Lorraine

Spots Global Cancer Trial Database for capthpv method